Cargando…
Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C
Background and Aims: Hepatitis C virus (HCV) cirrhosis is the leading indication for liver transplantation in the United States and recurrent HCV following liver transplantation is a major cause of allograft loss and mortality. Liver biopsies are commonly used to identify recurrent HCV and determine...
Autores principales: | Aby, Elizabeth, Jimenez, Melissa A., Grotts, Jonathan F., Agopian, Vatche, French, Samuel W., Busuttil, Ronald W., Saab, Sammy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606965/ https://www.ncbi.nlm.nih.gov/pubmed/28936400 http://dx.doi.org/10.14218/JCTH.2016.00073 |
Ejemplares similares
-
Elimination of Hepatitis C in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2018) -
Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use
por: Saab, Sammy, et al.
Publicado: (2016) -
Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience
por: Sheen, Victoria, et al.
Publicado: (2016) -
Accuracy and Safety of 1,055 Transjugular Liver Biopsies in Postliver Transplant Patients
por: Lee, Edward Wolfgang, et al.
Publicado: (2021) -
Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
por: Saab, Sammy, et al.
Publicado: (2017)